Randomized Trial of Aspirin and Cataracts in U.S. Physicians
Status:
Terminated
Trial end date:
1988-01-01
Target enrollment:
Participant gender:
Summary
To determine whether 325 mg of aspirin taken on -alternate days reduces the risk of
developing cataract among male U.S. physicians who were aged 40 to 84 in 1982.
To identify potential risk factors for cataract development, such as age, blood pressure,
blood cholesterol, height, diabetes, medication use, and history of previous eye trauma or
surgery.